PROGNOSTIC STAGE IIA BREAST CANCER AJCC V8
Clinical trials for PROGNOSTIC STAGE IIA BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new PROGNOSTIC STAGE IIA BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for PROGNOSTIC STAGE IIA BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough breast cancer: drug aims to boost immune attack
Disease control TerminatedThis study tested the drug abemaciclib in 26 women with triple negative breast cancer that did not respond to standard chemotherapy. The goal was to see if the drug could increase immune cell activity in the tumor before surgery. The trial was stopped early, but results may help …
Matched conditions: PROGNOSTIC STAGE IIA BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 25, 2026 04:11 UTC
-
Promising combo for Hard-to-Treat breast cancer hits roadblock
Disease control TerminatedThis study tested a combination of two drugs (nab-paclitaxel and alpelisib) given before surgery to people with a specific type of triple-negative breast cancer that didn't respond to standard chemotherapy. The goal was to see if the combo could shrink or eliminate tumors. Only 6…
Matched conditions: PROGNOSTIC STAGE IIA BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 25, 2026 04:06 UTC
-
Can a gut pill stop chemo stomach woes? trial tests rifaximin for breast cancer patients
Symptom relief TerminatedThis study tested the antibiotic rifaximin in 20 people with early-stage HER2-positive breast cancer who had stomach problems from pertuzumab-based chemotherapy. The goal was to see if rifaximin could reduce side effects like diarrhea and belly pain, helping patients stay on thei…
Matched conditions: PROGNOSTIC STAGE IIA BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 18, 2026 12:07 UTC